Prosecution Insights
Prosecution Insights
23 pending office actions • 16 art units • 23 examiners • 0 of 23 (0%) have an AI response strategy ready • 22 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (4%) |
| §101 + other | 2 (9%) |
| §103 only | 5 (22%) |
| §102 only | 2 (9%) |
| §112 only | 1 (4%) |
| Double-patenting + other | 1 (4%) |
| Multi-statute (no §101) | 11 (48%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALBERS, KEVIN S | 1 | 24.5% | +51.2% |
| MARVICH, MARIA | 1 | 54.7% | +28.1% |
| WILSON, MICHAEL C | 1 | 41.4% | +17.5% |
| LIPPOLIS, ALEXANDRA ROSE | 1 | 39.3% | +70.3% |
| AMICK, THOMAS RUSSE | 1 | 73.2% | +30.2% |
| MONTANARI, DAVID A | 1 | 64.8% | +49.2% |
| CHEN, STACY BROWN | 1 | 66.0% | +40.4% |
| SITTON, JEHANNE SOUAYA | 1 | 53.0% | +48.0% |
| CHONG, YONG SOO | 1 | 43.7% | +41.7% |
| BOECKELMAN, JACOB A | 1 | 36.1% | +46.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17919030 | Systems and Methods for Quantification of Liver Fibrosis with MRI and Deep Learning | TIEU, BENNY QUOC | 121d overdue |
| 17421908 | COMPOSITIONS AND METHODS FOR TREATMENT OF A MALABSORPTIVE DISORDER | REGLAS, GILLIAN CHELSEA | 91d overdue |
| 18104055 | NPERSEVERE: BIOMARKERS ESTIMATING BASELINE MORTALITY RISK FOR NEONATAL SEPSIS AND NECROTIZING ENTEROCOLITIS | IVICH, FERNANDO NMN | 62d |
| 18934187 | SKIN CARE FOR EXTREMELY LOW BIRTHWEIGHT INFANTS | ALBERS, KEVIN S | — |
| 18847004 | DELIVERY METHODS USING PLATELETS | MARVICH, MARIA | — |
| 18737201 | SELF-INACTIVATING LENTIVIRAL VECTOR ENCODING BETA- OR GAMMA-GLOBIN | WILSON, MICHAEL C | — |
| 18415949 | INTEIN TECHNOLOGY TO DELIVER ABCA3 LIPID TRANSPORTER FOR ABCA3 DEFICIENCY | LIPPOLIS, ALEXANDRA ROSE | — |
| 18473619 | COLONIC ORGANOIDS AND METHODS OF MAKING AND USING SAME | MONTANARI, DAVID A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18333934 | Microspheres Containing Decellularized Donor Tissue and Their Use in Fabricating Polymeric Structures | BOECKELMAN, JACOB A | 62d |
| 18276905 | INFLUENZA VACCINE COMPOSITIONS AND METHODS OF USING SAME | CHEN, STACY BROWN | 63d |
| 18934187 | SKIN CARE FOR EXTREMELY LOW BIRTHWEIGHT INFANTS | ALBERS, KEVIN S | — |
| 18847004 | DELIVERY METHODS USING PLATELETS | MARVICH, MARIA | — |
| 18737201 | SELF-INACTIVATING LENTIVIRAL VECTOR ENCODING BETA- OR GAMMA-GLOBIN | WILSON, MICHAEL C | — |
| 18415949 | INTEIN TECHNOLOGY TO DELIVER ABCA3 LIPID TRANSPORTER FOR ABCA3 DEFICIENCY | LIPPOLIS, ALEXANDRA ROSE | — |
| 18578381 | DIFFERENTIAL CXCR4 EXPRESSION ON HEMATOPOIETIC PROGENITOR CELLS VERSUS STEM CELLS DIRECTS HOMING AND LONG-TERM ENGRAFTMENT | AMICK, THOMAS RUSSE | — |
| 18473619 | COLONIC ORGANOIDS AND METHODS OF MAKING AND USING SAME | MONTANARI, DAVID A | — |
| Art Unit | Apps |
|---|---|
| 1638 | 3 |
| 1632 | 3 |
| 1672 | 2 |
| 3786 | 1 |
| 1682 | 1 |
| 1623 | 1 |
| 1655 | 1 |
| 1758 | 1 |
| 1633 | 1 |
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18934187 | SKIN CARE FOR EXTREMELY LOW BIRTHWEIGHT INFANTS | ALBERS, KEVIN S | 3786 | §103§112 | Non-Final OA | — | Pending | Oct 31, 2024 |
| 18847004 | DELIVERY METHODS USING PLATELETS | MARVICH, MARIA | — | §102§103§112 | Non-Final OA | — | Pending | Sep 13, 2024 |
| 18737201 | SELF-INACTIVATING LENTIVIRAL VECTOR ENCODING BETA- OR GAMMA-GLOBIN | WILSON, MICHAEL C | 1638 | §103§112 | Non-Final OA | — | Pending | Jun 07, 2024 |
| 18415949 | INTEIN TECHNOLOGY TO DELIVER ABCA3 LIPID TRANSPORTER FOR ABCA3 DEFICIENCY | LIPPOLIS, ALEXANDRA ROSE | — | §103§112 | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18578381 | DIFFERENTIAL CXCR4 EXPRESSION ON HEMATOPOIETIC PROGENITOR CELLS VERSUS STEM CELLS DIRECTS HOMING AND LONG-TERM ENGRAFTMENT | AMICK, THOMAS RUSSE | 1638 | §102 | Non-Final OA | — | Pending | Jan 11, 2024 |
| 18473619 | COLONIC ORGANOIDS AND METHODS OF MAKING AND USING SAME | MONTANARI, DAVID A | 1632 | §101§103Other | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18276905 | INFLUENZA VACCINE COMPOSITIONS AND METHODS OF USING SAME | CHEN, STACY BROWN | 1672 | §102§103§112DPOther | Non-Final OA | 63d | Pending | Aug 11, 2023 |
| 18229323 | Methods for Treating Eosinophilic Esophagitis | SITTON, JEHANNE SOUAYA | 1682 | §112 | Final Rejection | — | Pending | Aug 02, 2023 |
| 18272176 | METHODS FOR OPTIMIZING CFTR-MODULATOR THERAPY | CHONG, YONG SOO | 1623 | §102§103 | Non-Final OA | — | Pending | Jul 13, 2023 |
| 18333934 | Microspheres Containing Decellularized Donor Tissue and Their Use in Fabricating Polymeric Structures | BOECKELMAN, JACOB A | 1655 | §103 | Non-Final OA | 62d | Pending | Jun 13, 2023 |
| 18039391 | ENHANCED NANOPARTICLE DELIVERY SYSTEMS | KELLY, ROBERT M | 1638 | §102 | Non-Final OA | — | Pending | May 30, 2023 |
| 18252813 | REFINED USES OF GABA A RECEPTOR MODULATORS IN TREATMENT OF FRAGILE X SYNDROME | WHITE, DENNIS MICHAEL | 1758 | §102§103Other | Final Rejection | — | Pending | May 12, 2023 |
| 18250996 | PSEUDOTYPED PARTICLES, MODIFIED CELLS, RELATED COMPOSITIONS, AND RELATED METHODS | O'NEILL, MARISOL ANN | 1633 | §103 | Final Rejection | 32d overdue | Pending | Apr 28, 2023 |
| 18027900 | RAFT CULTURES AND METHODS OF MAKING THEREOF | MIANO, JOSEPH PAUL | 1631 | §103§112 | Final Rejection | — | Pending | Mar 22, 2023 |
| 18104055 | NPERSEVERE: BIOMARKERS ESTIMATING BASELINE MORTALITY RISK FOR NEONATAL SEPSIS AND NECROTIZING ENTEROCOLITIS | IVICH, FERNANDO NMN | 1678 | §103§112Other | Non-Final OA | 62d | Pending | Jan 31, 2023 |
| 17919030 | Systems and Methods for Quantification of Liver Fibrosis with MRI and Deep Learning | TIEU, BENNY QUOC | 2682 | §101 | Non-Final OA | 121d overdue | Pending | Oct 14, 2022 |
| 17910105 | MATERIALS AND METHODS FOR THE TREATMENT OF GAUCHER DISEASE | CURRENS, GRANT CARSON | 1651 | §103 | Final Rejection | 27d | Pending | Sep 08, 2022 |
| 17798190 | BRAIN FUNCTION MAPPING WITH INTRACRANIAL ELECTROENCEPHALOGRAM (EEG) USING EVENT-RELATED SPECTRAL MODULATIONS | UCHITEL, EMILY RUTH ABIGAIL | 3792 | §102§103§112 | Non-Final OA | — | Pending | Aug 08, 2022 |
| 17634148 | METHODS FOR MAKING ORGANOID COMPOSITIONS | BEHARRY, ZANNA MARIA | 1632 | §101§103§112Other | Non-Final OA | — | Pending | Feb 09, 2022 |
| 17627613 | METHOD OF TREATING NEOPLASTIC DISEASES WITH A CDC42-SPECIFIC INHIBITOR | PUTTLITZ, KARL J | 1646 | §103 | Non-Final OA | — | Pending | Jan 14, 2022 |
| 17617165 | RATIONAL THERAPEUTIC TARGETING OF ONCOGENIC IMMUNE SIGNALING STATES IN MYELOID MALIGNANCIES VIA THE UBIQUITIN CONJUGATING ENZYME UBE2N | PATTERSON, SARAH COOPER | 1675 | §103§112 | Non-Final OA | — | Pending | Dec 07, 2021 |
| 17603774 | VIRAL VECTOR MANUFACTURING METHODS | JADHAO, SAMADHAN JAISING | 1672 | §103Other | Final Rejection | 8d | Pending | Oct 14, 2021 |
| 17421908 | COMPOSITIONS AND METHODS FOR TREATMENT OF A MALABSORPTIVE DISORDER | REGLAS, GILLIAN CHELSEA | 1632 | §103§112 | Non-Final OA | 91d overdue | Pending | Jul 09, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial